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Background: Upper gastrointestinal cancer is the most common cancer in Ardabil Province, 
North-West of Iran, accounting for more than 50% of all cancer deaths in this area. We conducted 
this study to determine the present survival rate of patients with esophageal and gastric cancers 
before launching interventional studies. 
Methods: A prospective follow-up study of 420 biopsy-proven patients (127 females, mean 
age: 64) with upper gastrointestinal cancer (141 esophageal and 279 stomach cancers) who were 
initially diagnosed in Aras Clinic, the main gastrointestinal referral center of Ardabil Province, from 
2000 through 2004, was performed with collection of data on demographics, tumor characteristics, 
pathologic stage, treatment methods, complications, survival time, etc. Data were gathered 
through direct interview with patients or their families in 303 cases and evaluation of death 
certificates in 55 patients. Follow-up was from cancer diagnosis until death, or immigration. 
Survival according to stage of disease, Lauren tumor type, tumor location, surgery, and adjuvant 
chemotherapy was analyzed, and results were compared with those of western series. 
Results: Sixty-two cases were lost to follow-up. The one- and five-year survival rates in the 
patients with upper gastrointestinal cancer in Ardabil Province were 40.5%, and 0.8%, respectively. 
In the univariate analysis, men had a slightly lower survival rate than women (P = 0.21) and patients 
with esophageal cancer had a longer survival rate compared to stomach cancer patients (P = 0.15). 
Patients who had undergone surgery (P < 0.001) and/or chemotherapy (P < 0.001) survived longer 
than those without such treatments. Tumor morphology, age at diagnosis, radiotherapy, alcohol, 
and opium consumption did not show any significant effects on the survival rate of patients. In 
multivariate analysis, only smoking was remained as an independent factor for stomach cancer (P 
= 0.04) while in esophageal cancer, surgery and grade of differentiation were significant predictors 
of survival. 
Conclusion: Survival rate of stomach and esophagus cancer cases in Ardabil is relatively low. 
Intervention for early detection and therapy is necessary to increase survival. 
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Introduction 
 
astric cancer is the second leading cause 
of cancer death worldwide and is the 
most common type of cancer in Iran.1, 2 
Gastric and esophageal cancers are the most 
frequent causes of cancer-related deaths in Iran 
with the highest rates reported from northern part 
of the country.1,3,4 Survivals of gastric and 
esophageal cancers has been studied in multiple 
series with patients stratified by stage of  
disease, Lauren  tumor  type,  tumor  location,  and   
 
type of therapy. An association between survival 
and stage of cancer has been shown by all studies. 
Several authors also reported that 5-year survival 
have  improved   over  the  past  several  decades.2 
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Mortality rates of gastric cancer are particularly 
high in Asia, South America, and parts of Europe. 
According to a study conducted by Digestive 
Disease Research Center (DDRC) during 1996 to 
2000, upper gastrointestinal (GI) malignancies 
constituted nearby half of all malignancies in the 
province.5 – 7 The objective of this study was to 
estimate the survival rate of patients with gastric or 
esophageal cancer by histopathologic type, grade 
of tumor, treatment modalities, and location of 
tumor as well as some of the risk factors of  upper 
GI malignancies such as consumption of alcohol or 
opium, cigarette smoking, and age at the diagnosis.  
 
Patients and Methods 
 
A prospective review of all the 420 biopsy-
proven patients with upper GI cancers (141 
esophagus, and 279 stomach) who were initially 
diagnosed at the referral unique clinic for upper GI 
malignancies located in the main city of Ardabil 
for 5 years, from 2000 through 2004, was planed. 
There were 293 males and 127 females with a 
mean age of 64 (range: 20 – 90) years.  
International classification of disease for 
oncology (ICD-O-3) was used for coding 
morphology and topography of tumors. In this 
study, we looked at the parameters such as overall 
survival, demographic data, symptoms and signs, 
risk factors, histopathology, and socioeconomic 
status. 
We contacted patients or their families through 
visiting their residential place and performed a 
direct interview with them. All of the interviews 
were done by a physician or a trained nurse. With 
this method, we collected data from 303 cases. We 
found date of death of other 55 patients by 
evaluation of official death certificates. 
Information on 62 patients was missing due to 
inaccessible home address, address change, or 
immigration. Data on risk factors and demographic 
variables were obtained from questionnaires which 
completed at the time of diagnosis at Aras Clinic. 
Survival analysis was performed using STATA 
software, release 8. Kaplan-Meier method was 
used to estimate the survival probability and Cox 
proportional hazards model was used for 
multivariate analysis of risk variables.8, 9, 17 
 
Results 
 
Among 358 observed patients at the end of the 
study, 331 patients were dead and only 27 were 
still alive. Fifty-five percent of patients were rural 
inhabitants. Demographic and socioeconomic 
characteristics of patients are shown in Table 1. 
Dysphagia was the most common presenting 
complaint observed in 44% of patients; weight loss 
was another common presenting feature reported 
by 15% of patients. 
According to univariate analysis (log-rank test), 
the factors influencing the overall survival rate for 
both cancers together were undergoing surgery 
(either alone or in combination with chemo/radio-
therapy for both stomach and esophagus: P < 
0.009), receiving chemotherapy (in combination 
with surgery: P = 0.001; chemo-therapy alone: P = 
0.087), and tumor grades (P < 0.001); 
undifferentiated type had the lowest survival 
(median: 5 months) while those with well- 
differentiated tumor had the longest survival 
(median: 9 months). After further stratification by 
site of tumor, differentiation of tumor and 
chemotherapy did not reach the statistical 
significance anymore for esophagus. Age at the 
diagnosis, tumor site (stomach or esophagus), 
tumor  morphology,  alcohol  drinking,  and  opium  
Table 1. Baseline characteristics of patients.
 Stomach cancer 
Esophagus 
cancer 
  n (%) n (%) 
Sex   
Female 62 (22.2) 65(46.1) 
Male 217 (77.8) 76(53.9) 
Age group   
< 40 10 (3.6) 3 (2.1) 
40 – 49  14 (5.0) 13 (9.2) 
50 – 59  45 (16.1) 28 (20.1) 
60 – 69  109 (39.1) 40 (28.4) 
≥ 70  101 (36.2) 57 (40.4) 
Residence   
Rural 141 (51.5) 86 (62.3) 
Urban 133 (48.5) 52 (37.7) 
Education   
0 191 (89.3) 111 (95.7) 
1 – 5 years 16 (7.5) 4 (3.5) 
6 – 8 years 1 (0.5) 1 (0.9) 
9 – 12 years 4 (1.9) 0 (0) 
>12 years 2 (0.9) 0 (0) 
 Smoker    
No 147 (64.5) 70 (56.5) 
Yes 81 (35.5) 54 (43.6) 
Alcohol   
No 218 (98.2) 120 ( ) 
Yes 4 (1.8) 2 (1.6 ) 
Opium   
No 208 (93.7) 112 (91.1 ) 
Yes 14 (6.3) 11 (8.9 ) 
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consumption had  no   effects   on  survival  rate of 
patients with upper GI cancer.  
 The 1 and 5-year survival rate for all upper GI 
cancer patients was 40.5%, and 0.83%, 
respectively. In terms of overall cumulative 
survival observed for five years, patients with 
esophagus cancer had a slightly higher survival 
rate than patients with stomach cancer (P = 0.15). 
Figure 1 shows that patients with esophageal 
cancer had a better survival than those with gastric 
cancer (P = 0.15) Survival of patients with 
stomach cancer in cardia was slightly better than 
those with tumor involving other gastric regions  
(P = 0.19). 
Only 28% of patients had undergone a curative 
resectional surgery. About 25% of patients did not 
receive any treatment at all (Table 2).  
Figure 2 shows the difference between 
cumulative survival of patients with operated 
esophageal cancer and those with no surgery, 
regardless of other additional treatments  
(P < 0.001).  
 The mean (median) survival rate for patients 
with esophageal cancer was 12.1 (9) months and 
for those with gastric cancer was 11.8 (9) months. 
In those with stomach cancer, patients with the 
histopathology of “signet ring cell carcinoma” had 
the lowest survival rate (median: 8 months); other 
cases lived more than 23 months after the 
diagnosis. 
Figure 3 shows that in the entire follow-up, the 
overall mortality was higher for those with 
stomach cancer than esophagus. The mortality rate 
increased steeply from the time of diagnosis for 
one year, when the rate became steadier for 
stomach than esophagus cancer, which had a 
decline after the third year. 
The effect of tumor site, gender, age, and place 
of residence on the prognosis was not significant in 
a multivariate model adjusted for follow-up time. 
The mortality ratio of esophageal vs. gastric 
malignancies was 0.86 (CI95%: 0.6 – 1.1). This ratio 
for residential place (urban vs. rural) was 1.03 
(CI95%: 0.8 – 1.3). 
The multivariate analysis of potential 
prognostic factors in patients with stomach cancer 
showed that smoking status had a significant 
prognostic value associated with 81% increase in 
mortality rate (P = 0.04). Nevertheless, place of 
residence, age, and sex had no prognostic values 
for stomach cancer, after adjustment for other 
variables included in the model. Based on this 
database, surgery and chemotherapy seem to be 
effective  treatments   for    stomach  cancer   while  
 
Figure 1. Comparing survival probability of patients with gastric and esophageal cancers using Kaplan-
Meier survival analysis. 
Table 2. Treatment modality among patients with upper GI cancer.
 Cancer 
Surgery 
alone  
(%) 
Chemotherapy 
alone 
(%) 
Radiotherapy 
alone 
(%) 
Surgery and 
chemo/radiotherapy 
(%) 
Supportive care 
(%) Total 
Stomach  14.0 4.3 0.4 12.5 25.8 279 
Esophagus 19.1 6.4 0.0 12.1 24.1 141 
Both 15.7 5.0 0.2 12.4 25.2 420 
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radiotherapy associated with higher mortality, 
although none of these findings reached statistical  
significance. Mortality in educated patients was 
half of that in illiterates (P = 0.10). Those with 
diffuse type of adenocarcinoma of stomach had 
37% higher mortality than those with the intestinal 
type of adenocarcinoma (CI95% for mortality ratio: 
0.30 – 6.33). 
 In patients with esophageal cancer, taking all 
other factors (e.g., age, gender, other treatments, 
etc.) into account, surgery was significantly 
associated with lower mortality while radiotherapy 
seemed to be associated with higher mortality  
(P = 0.46). Drinking alcohol was highly associated 
with the increased mortality of esophageal cancers 
(hazard ratio = 7.5; CI95%: 0.82 – 69.1).  
 
Discussion  
 
According to studies in Ardabil Province, upper 
GI cancers have high incidence and mortality. 
These cancers include around half of total cancers 
and more than half of causes of cancer-related 
deaths.3, 6, 7 The average age at diagnosis in our 
patients was 64 years while the mean age at 
presentation in our neighboring country, Pakistan, 
is 56 years.8 These cancers are, therefore, disease 
of the elderly in this province.5, 8 
 
Figure 2. Survival of patients with esophageal cancer, effect of surgery using Kaplan-Meier method.  
 
Figure 3. Mortality rate by site of cancer (smoothed hazard estimates). 
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Squamous cell carcinoma of the esophagus 
(85%) was the predominant histology seen in our 
study, with adenocarcinoma (14%) being less 
common. These data are consistent with data from 
most of other Asian countries.11, 13 These figures 
are different from those found in the developed 
countries where adenocarcinoma is becoming a 
more common type of histology in esophageal 
cancers.13, 16, 18 In our study, the survival of patients 
with esophagus cancer was slightly more than 
patients with stomach cancer (P = 0.26); these 
figures are different from those found in the 
countries such as England and South Korea.11, 19 
Women with esophagus cancer had a slightly 
longer survival than men in Ardabil Province; 
these data are consistent with data form European 
countries.16, 20 Signet ring cell histopathologic type 
of tumors in this study had significantly lower 
survival than other types of histopathology in 
patients with stomach cancer. Nonetheless, in 
another study, there was no difference between 
types of histopathology.14 
The average survival time in our patients is 
similar to other developing countries such as 
Pakistan. The median time of survival in our study 
was 9 months while in Pakistan it was 7 months.8 
These data, however, are different from those 
reported from England, Korea, and China.11, 12, 19 
The overall survival rate for our series (both 
men and women) was 40.5% after one year, 16.9% 
after two, 6.5% after three, 2.5% after four, and 
less than 1% after five years. These data are 
different from those reported from developed 
countries or China.13,14,16 For example, in China the 
1 to 5-year survival rates in the patients with 
stomach cancer were reported to be 54.2%, 41.8%, 
37.9%, 34.0%, and 30.5%, respectively.10 In the 
multivariate Cox proportional hazards model for 
stomach cancer, the only statistically significant 
explanatory variable was smoking status, which 
shows ever-smoking is associated with lower 
survival (adjusted for other factors in the model, 
Table 3). In our multivariate Cox proportional 
hazards model for esophageal cancer, the only 
statistically significant explanatory variable was 
surgery, which showed that patients who had 
undergone surgery had 51% lower mortality than 
those who had received other treatment modalities 
(i.e., chemotherapy and radiotherapy). 
Although there are reports that surgery 
improves the survival, even in stage IV upper GI 
cancers,15 judgment on the effect of any treatment 
on survival, based on these data, is not correct, 
because those patients who take a treatment like 
surgery are different from others in respect to their 
health condition like cardiovascular status; it is 
more likely that only those patients with healthier 
condition can undergo surgery. Therefore, a better 
survival of operated patients might be attributed to 
their health status that made them being selected 
for surgery. The same argument may be applicable 
to those who underwent radiotherapy, which had a 
higher mortality; the patients might have been 
chosen for this treatment for they had nonoperable 
metastasized tumors. This issue should be further 
studied by randomized controlled trials. 
Although staging of tumor had not been 
recorded in our database, these results may reflect 
that higher proportion of patients with advanced 
tumor stage were visiting this referral tertiary 
clinic. Another reason for obtaining such a short 
survival rate might be due to the fact that we have 
a 15% loss in the follow-up; if we suppose all of 
them were alive, the survival rates could be 
substantially higher. Therefore, results of this study 
may not be representative of all upper GI cancer 
Table 3. Effects of explanatory variables on stomach and esophagus cancer mortality using Cox 
proportional hazards model. 
 Gastric cancer  Esophageal cancer 
Variable Mortality ratio (95% CI) Mortality ratio (95% CI) 
Sex (female/male) 0.97 0.47 – 2.00 1.29 0.72 – 2.33 
Age  1.00 0.97 – 1.04 0.99 0.97 – 1.02 
Residence (urban/rural) 0.75 0.45 – 1.27 1.30 0.76 – 2.24 
Surgery 0.67 0.33 – 1.34 0.49 0.27 – 0.89 
Chemotherapy  0.59 0.27 – 1.30 0.62 0.30 – 1.26 
Radiotherapy  1.59 0.39 – 6.52 1.52 0.50 – 4.67 
Smoking 1.81 1.02 – 3.23 0.87 0.49 – 1.56 
Alcohol drinking — — 7.51 0.82 – 69.10 
Opium use — — 0.92 0.35 – 2.41 
Adenocarcinoma / SCC — — 0.67 0.28 – 1.61 
Differentiation  
(well or moderate / poor or non-) 0.93 0.55 – 1.57 0.32 0.13 – 0.82 
Education (yes/no) 0.50 0.10 – 2.47 1.32 0.44 – 3.93 
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cases in Ardabil or Iran, but could demonstrate the 
fact that the majority of patients with upper GI 
cancers at a referral clinic, have a short survival 
after diagnosis. 
In conclusion, the overall survival rates for 
upper GI malignancies in this gastroenterology 
clinic in Ardabil Province are relatively low. Since 
stage of cancer is a very important factor 
influencing survival of patients with upper GI 
cancer, these short survival rates can be due to the 
fact that patients with upper GI cancer in Ardabil 
are, in general, referring to physicians at late stages 
of the disease. Surgery might be an effective 
treatment for all patients with upper GI cancer in 
Ardabil, especially for those with cancer of 
esophagus.1 Smoking is associated with decreased 
survival of patients with stomach cancer. 
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